anti-BORDETELLA PERTUSSIS LPS antibody product blog
Tags: Antibody; Monoclonal Antibody; BORDETELLA PERTUSSIS LPS; anti-BORDETELLA PERTUSSIS LPS antibody;
The BORDETELLA PERTUSSIS LPS n/a (Catalog #MBS213240) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s BORDETELLA PERTUSSIS LPS can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF), Western Blot (WB).ELISA: Minimum Dilution: 1/20; Maximum Dilution: 1/200;
Immunofluorescence: Minimum Dilution: 1/10; Maximum Dilution: 1/50;
Western Blotting: Minimum Dilution: 1/10; Maximum Dilution: 1/50. Researchers should empirically determine the suitability of the BORDETELLA PERTUSSIS LPS n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse anti Bordetella pertussis, clone 5111 is specific for lipooligosaccharide A (LOS-A) of Bordetella pertussis and Bordetella bronchiseptica. Bordetella lipopolysaccharides (LPS) are characterised by the absence of the O-polysaccharide (O-antigen) but have an extended core region and are more commonly termed as LOS. B. pertussis is a non-motile, gram-negative bacteria that is the common causative agent for whooping cough. B. bronchiseptica is a closely related species that is often involved in respiratory tract infection in smaller mammals.
Perservative Stabilisers: 0.1% Sodium Azide (NaN3). Buffer Solution: Phosphate buffered saline
Target Species: Bacterial. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing BORDETELLA PERTUSSIS LPS are readily searchable from our website. Different antibodies against the same target such as BORDETELLA PERTUSSIS LPS may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.